The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial (263932)
ARTG Name
KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial
Product name
KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
pembrolizumab
Licence category
REPI
Licence status
A
Summary
Product Information
Consumer Medicine Information